To help resolve the mechanistic bases for haematological adaptations (, 28% increase in red blood cell volume) of equids to high altitude (3800 m, barometric pressure P b , 487 mm Hg) and exercise, plasma erythropoietin concentration ([EPO]) was measured at rest and following exercise in six, moderately fit equids (four Arabians, one Quarter Horse and one Shetland Pony; four females and two males; age 9.0^4.5 years (mean^SD)).
Introduction
Humans and animals perceive inspiratory hypoxia and the ensuing hypoxaemia as a major threat to mortality and physiological homeostasis and are genetically designed to incur acute (e.g. hyperventilation via carotid bodies) and chronic (e.g. polycythaemia, angiogenesis, up-regulation of hypoxia-inducible factor) adaptations to defend oxygen transport 1, 2 . Central to these adaptations is the increased haemoglobin concentration ([Hb] ) that is driven by renal hypoxic sensitivity, which stimulates increased production and circulating plasma concentrations of the peptide hormone erythropoietin ([EPO]) [3] [4] [5] [6] [7] [8] [9] [10] [11] . With respect to arterial hypoxaemia at sea level, humans may experience exercise-induced arterial hypoxaemia, but it is neither as common nor as severe as that experienced during heavy-and severe-intensity exercise in the horse [12] [13] [14] [15] [16] . Thus, one would not expect to find elevated [EPO] following exercise in humans and, with one exception following marathon running 17 , this is true [18] [19] [20] [21] . Notwithstanding that the lactic acidosis of heavy/severe-intensity exercise is expected to oppose [EPO] production 18 , whether short-term heavy or severe exercise increases plasma [EPO] in the horse at sea level is unknown. It is pertinent that this mechanism has been proposed to account, in part, for overtraining-induced 'red cell hypervolaemia' diagnosed in Swedish Standardbred race horses 22, 23 . Moreover, a further interesting question is whether the plasma [EPO] response to exercise might be different against the background of hyperventilation-induced alkalaemia consequent to hypoxaemic stimulation of the peripheral chemoreceptors at altitude.
Unlike humans, the horse has a large (up to 14 kg) spleen that acts as a reservoir for red blood cells (RBCs) such that, during severe-intensity exercise, the circulating haematocrit can be almost doubled (i.e. from , 30 to 60-70%, in the extreme) 16 . Hence, with regard to O 2 transport, the horse has a degree of freedom for increasing tissue(s) O 2 supply without the necessity for making new RBCs per se. Thus, it might be argued that the presence of this mechanism may reduce the necessity or inclination for the horse to elevate its whole-body RBC mass via [EPO]-induced stimulation of RBC production. Counter to this argument, we found that total RBC volume increased by , 26% over a , 10 day sojourn at high altitude (i.e. 3800 m) 24 . Whether this was the result of increased plasma [EPO] was not determined.
The purpose of this investigation was to explore the effects of altitude and exercise in separatum and combined on plasma [EPO] 
Materials and methods

Animals
Six healthy horses (four Arabians, one Quarter Horse and one Shetland Pony), four females and two males, with an average age of 9.0^4.5 years (mean^SD) were used in the study. Body masses averaged 467^15 kg for the horses and 257 kg for the pony. Each animal was accustomed to running on the treadmill and to all the test protocols used in this investigation. The animals were physically conditioned for at least 4 months, after which they began a monitored training program, where they were conditioned 3 days per week on a treadmill (SÄTO I; Equine Dynamics Inc., Lexington, KY, USA) at walk, trot and canter for a total of 30 min each session. Training also included an exercise test performed on a dirt track, 2 days a week. Heart rates (HRs) were monitored during all exercise periods using a HR meter (Polar Vantage XL; Polar CIC, Inc., Port Washington, NY, USA). Prior to transport to high altitude (2.5 weeks), horses were exercised on the treadmill to determine their individual maximal HRs and maximal exerciseinduced haematocrit. This exercise regime involved an 8 min warm-up at 3.5 m s 21 and increases in treadmill speed by 1 m s 21 at 1 min intervals until the horse would no longer maintain its position on the treadmill despite humane encouragement. This test was repeated 1 week later.
General protocol
The experimental paradigm and general testing protocol used for this experiment are detailed in Fig. 1 . Blood gases, haematological changes and performance effects of this protocol have been published 24, 25 .
[EPO] was measured in venous blood samples obtained at rest and following exercise on a dirt track both at sea level (, 225 m) and high altitude, and on a treadmill at sea level in horses. Resting [EPO] was measured initially on 2 days at sea level (mean day T a , 218C and average P b , 743 mm Hg), over the course of a 10 day exposure to 3800 m altitude (mean day T a , 158C and P b , 487 mm Hg), and at rest for 2 days after return to sea level. The effects of exercise were examined by measuring [EPO] in samples obtained before and after the submaximal test (speed set-to-HR), which was performed on either of the 2 days pre-high-altitude exposure and on 3 days (days 2, 4 and 8) at 3800 m. Additional samples were obtained during a maximal incremental treadmill exercise test performed on either of the 2 days prior to high-altitude exposure and on one of the 2 days following return to sea level.
Jugular catheters (volume , 1.5 ml 21 , w Check-Flo Blue Introducer Set, 8F; Cook Inc., Bloomington, IN, USA) were used for all sampling. Catheters were inserted using aseptic procedures and the site protected with bandaging material. Catheters were flushed twice daily with heparinized saline and were replaced approximately every 72 h (or as needed). Twenty millilitres of blood were withdrawn prior to actual blood sampling to ensure that residual blood/ saline was cleared from the catheter.
Blood samples were collected in pre-chilled heparinized syringes from resting horses on each of the 2 days prior to transport. On the third day of the study (i.e. day 1 at altitude), the animals were transported 500 km to the Barcroft Facility of the University of California, White Mountain Research Station in the White Mountain range (3800 m), an approximately 13 h journey. On the day of transport to altitude, the blood sample was collected 3 h after reaching the research station (at , 17.00 hours). Subsequently, blood samples were collected 90 min postprandial (08.15 hours) on days 2, 4 and 8 of exposure to high altitude. The animals were transported back to sea level on study day 10, with resting blood samples collected 2 days, following return from high altitude.
The submaximal (track) test was performed on either of the 2 days, pre-altitude transport (i.e. at sea level), and on days 2, 4 and 8 of exposure to high altitude (3800 m). The maximal incremental treadmill test was performed at sea level once (within 2 days) prior to altitude exposure (on the alternate day from the submaximal track test) and on each of the 2 days upon return to sea level (no track test was run upon return to sea level because of potential interference with the treadmill test).
Submaximal exercise test on the track
The track test was performed on a 200 m long, compacted dirt, oval track. The test was preceded by a 15 min walking warm-up period. Subsequently, the submaximal test was standardized using HR, and consisted of 5 min walking, a 4 min trot (HR 110 bpm), a 4 min canter (HR 150 bpm) and a 2 min gallop (HR 180 bpm). At the completion of the gallop phase, the animals were allowed a 15 min recovery period consisting of 5 min walking and 10 min standing. An oval track was also prepared at the high-altitude site, and the submaximal test at altitude used the same HRs to standardize exercise 'intensity'. Blood samples and assays An aliquot of blood (10 ml 21 ) was collected into prechilled tubes containing sodium heparin (Vacutainer; Becton-Dickinson, Inc., Parsippany, NJ, USA). Blood was immediately centrifuged, and the plasma was separated and frozen in liquid nitrogen. Upon returning to sea level, the samples were transferred and stored at 2 708C until analysis.
[EPO] was measured using a commercially available radioimmunoassay kit (Incstar, Inc., Stillwater, MN, USA). Previous studies have demonstrated that equine [EPO] is highly homologous with other mammalian species [26] [27] [28] , and this particular radioimmunoassay has a reported 100% specificity for a-erythropoietin. Serial dilutions of equine plasma demonstrated that the radioimmunoassay and laboratory procedures utilized were reproducible and accurate. Samples were run in one batch against the manufacturer's standards with a withinassay coefficient of variation (CV) of 7%.
Statistical analysis
Data were analysed (Sigmastat 2.0; Jandel Scientific, Chicago, IL, USA) using ANOVA for repeated measures. Post hoc separation of means utilized the StudentNewman-Keuls method. The null hypothesis was rejected when P , 0.05.
Results
High-altitude exposure increased [EPO] by 387% (P , 0.05) within the first day (Fig. 2) . However, 12 h later on the second day at high altitude, [EPO] had returned to pre-altitude levels (P . 0.05) (Fig. 2) .
[EPO] did not change significantly over the remaining 8 days at altitude nor during the 2 days following return to sea level. Moreover, [EPO] did not change significantly in response to acute exercise performed either at sea level or at 3800 m (Fig. 3) .
Discussion
The principal original findings from this investigation are that: (1) Comparison with previous findings Whereas the baseline [EPO] levels found for the equine in this study were well within the range reported for other species 26, 28 , they were substantially higher than those found previously for horses 29, 30 . This investigation used standard radioimmunoassay techniques and a kit validated for use in the measurement of [EPO] 
Experimental considerations
The molecular structure and molecular weight of equine [EPO] are highly homologous with those characterized for other mammalian species [26] [27] [28] . However, this experiment is one of very few to use commercially available radioimmunoassay kits to measure [EPO] in equids 29, 30 . The Incstar, Inc. assay kit used in this study employs human recombinant [EPO] antibodies and, thus, to provide additional confidence that the [EPO] measurements were valid, tests of parallelism were performed using serially diluted plasma. The resulting measured concentrations demonstrated linear parallelism over a broad range of concentrations. A concentration-dependent decrease in optical density has also been demonstrated using serially diluted horse plasma and Western blot techniques 27 . Collectively, these results provide confidence that the Incstar, Inc.
[EPO] radioimmunoassay kit used in this study measured [EPO] with high fidelity.
A second concern was that the appreciable stresses involved in transporting the animals several hundred miles to the high-altitude facility, rather than the hypobaric hypoxia itself, might have contributed to, or indeed caused, the significant [EPO] elevation reported. This concern was addressed by examination of effects of the return trip to sea level, which was of similar duration and therefore potential to induce stress, on [EPO] . As evident in Fig. 3 , there was absolutely no increase in [EPO] following the return journey, effectively alleviating this concern.
Effects of high altitude on plasma [EPO]
It is pertinent that [EPO] was increased after only 3 h at 3800 m, which would appear to be too rapid to be explained by de novo synthesis of [EPO] after a hypoxic stimulation, which reportedly takes , 6 h, at least in humans 5 . However, the total time taken to ascend to the Barcroft Research Station was , 13 h; thus, ample time was available for stimulation of [EPO] synthesis. Interestingly, the rapid [EPO] increase was temporary, with a return to baseline evident by the second day at altitude. The temporary increase in equid [EPO] in this investigation is similar to observations made in some (4900 and 7600 m) 31 but certainly not all (2315 m) 3, 4, 8, 9 altitude studies of humans. As mentioned earlier, one substantial structural and functional attribute of the equine (but not human) O 2 transport system is the large, contractile spleen, which, under conditions of exercise 14, 16, 22, 32 or altitude 24 stress, can augment systemic haematocrit and ameliorate or counter the O 2 transport deficits resulting from arterial hypoxaemia. Indeed, it is likely that this effect, in addition to a reduced plasma volume (revealed by increased plasma [protein] 24,25 , was principally responsible for the elevated resting haematocrit (from , 35 to 45%) found for these horses after just 2 days at high altitude 24 ; this response occurred too rapidly for [EPO]-induced erythropoiesis and thus that increase in haematocrit must have been due to mobilization of the splenic red cell reserve. Notwithstanding the above, there is some suggestion that body RBC mass may have increased for the animals in this investigation 24 . This includes the following: (1) resting packed RBC volume measured at sea level increased by , 6% from pre-to post-high (i.e. after 10 days) altitude in the face of altitude-induced elevation of plasma and total blood volume; and (2) during the track exercise test, which was equated to cardiovascular stress (HR), there was a modest, though significant, increase in packed RBC volume from that observed pre-altitude and at day 2 at altitude compared with that present at day 8 of altitude exposure. This would represent evidence of altitude-induced erythropoiesis only if normalizing for HR did indeed mean that sympathetic splenic contraction was not greater at day 8 than previously -which could not be determined. One consideration, which mitigates against an increased rate of erythropoiesis, is that an [EPO]-induced red cell increase in RBC production in the horse is thought to take multiple and/ or sustained elevations in [EPO] 10,32,33 beyond the exposure observed in this study. Such is also the case in humans and other species 5, 6, 7, 34 , and it is pertinent that high-altitude exposure does cause a sustained elevation of [EPO] in humans and mice 3, 8, 9 . Studies of the effects of rhuEPO administration on the horse have shown that increases in RBC volume are not apparent until after 2-3 weeks of repeated rhuEPO administration 10, 32, 34 . Finally, while purely speculative, the observed lack of a sustained plasma [EPO] response in the horses of this study may also suggest that any drop in the level of arterial oxygen tension in renal blood was not low enough to stimulate sustained elevations of [EPO] release despite the combined effects of exercise and altitude. In contrast to humans and other species, it may be that, with regard to hypoxaemic stimulation of sustained renal [EPO] release, the horse has developed a greater tolerance than humans and other species, possibly due to its history of exercise-induced arterial hypoxaemia.
Effects of exercise on plasma [EPO]
Elevated RBC mass, circulating haematocrit and arterial O 2 concentration elevates maximal O 2 uptake (i.e. _ VO 2 max ) and enhances exercise performance 16, [35] [36] [37] . Contrary to our first hypothesis, acute short-duration exercise, on its own or in combination with high altitude-induced arterial hypoxaemia, does not appear to stimulate increased [EPO] in equids (Fig. 3 ). This corresponds with most of the evidence in humans that, across multiple intensities and durations, acute exercise does not elevate [EPO] 18-21 . The single report that a transient increase in [EPO] occurred 31 h following marathon running may have been the result of that particular event causing dehydration and an extended period of exercise-induced decreases in renal blood flow 17 . In contrast, a compelling weight of evidence indicates that exercise training does not increase RBC mass 38 , and further that highly trained humans might actually evidence a mild reduction in haematocrit 39 . However, beyond an initial erythropoiesis stimulation to counter the rapid plasma volume increase that typically attends the first week of exercise training 40 , teleologically, if repeated exercise did cause a sustained [EPO] elevation, this might lead eventually to RBC polycythaemia and potentially pathological increases in blood viscosity such as observed in the high altitude-derived Monge's disease 41 . In marked contrast to humans, horses evince a marked exercise-induced arterial hypoxaemia 16 , and this supported our hypothesis that acute exercise might elevate [EPO] . However, this investigation suggests that such is not the case and, in so doing, undermines the speculation that exercise-induced [EPO] elevations might be causative for the overt polycythaemia found in exercise-(over)-trained Swedish Standardbred race horses 22, 23 , which has not been reported for other highly trained race-horse populations.
One possible explanation for the lack of an effect of heavy-or severe-intensity exercise and/or the combined effects of such exercise and high-altitude exposure on [EPO] may be the inhibitory effect of acidaemia on [EPO] production and release by the kidney 18 . While blood pH was not measured during exercise in this study, the horses were exercised at an intensity (180 bpm) -as shown in many other studies -to be sufficient to constitute heavy-or severe-intensity exercise and, by definition, invoke a metabolic acidaemia 12, 14, 16, 32, 42, 43 . At rest at altitude, the horses experienced an increase in arterial pH consequent to hypoxaemic stimulation of the peripheral chemoreceptors 25 . However, because this respiratory alkalemia is countered chronically by a reduction in blood-buffering capacity, as the kidneys excrete bicarbonate and retain hydrogen ions, a greater exerciseinduced acidaemia would be expected at altitude. In turn, this greater acidaemia may further oppose any hypoxaemically driven elevation of [EPO] .
Conclusions
This investigation demonstrates that equid plasma [EPO] increases substantially and rapidly upon exposure to high altitude. However, this [EPO] elevation subsides within 2 days of altitude exposure. In contrast, neither acute bouts of heavy/severe-intensity exercise at sea level nor during the hypoxaemia that attends high-altitude exposure increased [EPO] . These findings help explain why repeated exercise bouts do not elevate rest or exercising haematocrit in most equids, despite the attendant marked hypoxaemia. They do not, however, support a mechanism for any increased RBC mass that may result from an ,10 day sojourn at high altitude 24 .
